全文获取类型
收费全文 | 678篇 |
免费 | 138篇 |
国内免费 | 38篇 |
出版年
2024年 | 2篇 |
2023年 | 27篇 |
2022年 | 26篇 |
2021年 | 30篇 |
2020年 | 27篇 |
2019年 | 38篇 |
2018年 | 28篇 |
2017年 | 30篇 |
2016年 | 30篇 |
2015年 | 26篇 |
2014年 | 54篇 |
2013年 | 45篇 |
2012年 | 26篇 |
2011年 | 37篇 |
2010年 | 33篇 |
2009年 | 40篇 |
2008年 | 35篇 |
2007年 | 34篇 |
2006年 | 35篇 |
2005年 | 35篇 |
2004年 | 39篇 |
2003年 | 24篇 |
2002年 | 27篇 |
2001年 | 17篇 |
2000年 | 20篇 |
1999年 | 12篇 |
1998年 | 3篇 |
1997年 | 9篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1993年 | 9篇 |
1992年 | 7篇 |
1991年 | 6篇 |
1990年 | 9篇 |
1989年 | 4篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 6篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 2篇 |
1979年 | 4篇 |
1978年 | 1篇 |
1975年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有854条查询结果,搜索用时 93 毫秒
851.
852.
Qiang Hu Liang Zhu Yanyan Liu Jianguo Sun Deo Kumar Srivastava Leslie L. Robison 《Biometrical journal. Biometrische Zeitschrift》2020,62(8):1909-1925
For the analysis of ultrahigh-dimensional data, the first step is often to perform screening and feature selection to effectively reduce the dimensionality while retaining all the active or relevant variables with high probability. For this, many methods have been developed under various frameworks but most of them only apply to complete data. In this paper, we consider an incomplete data situation, case II interval-censored failure time data, for which there seems to be no screening procedure. Basing on the idea of cumulative residual, a model-free or nonparametric method is developed and shown to have the sure independent screening property. In particular, the approach is shown to tend to rank the active variables above the inactive ones in terms of their association with the failure time of interest. A simulation study is conducted to demonstrate the usefulness of the proposed method and, in particular, indicates that it works well with general survival models and is capable of capturing the nonlinear covariates with interactions. Also the approach is applied to a childhood cancer survivor study that motivated this investigation. 相似文献
853.
《Indian pacing and electrophysiology journal》2021,21(6):367-393
In view of the increasing complexity of both cardiovascular implantable electronic devices (CIEDs) and patients in the current era, practice guidelines, by necessity, have become increasingly specific. This document is an expert consensus statement that has been developed to update and further delineate indications and management of CIEDs in pediatric patients, defined as ≤21 years of age, and is intended to focus primarily on the indications for CIEDs in the setting of specific disease categories. The document also highlights variations between previously published adult and pediatric CIED recommendations and provides rationale for underlying important differences. The document addresses some of the deterrents to CIED access in low- and middle-income countries and strategies to circumvent them. The document sections were divided up and drafted by the writing committee members according to their expertise. The recommendations represent the consensus opinion of the entire writing committee, graded by class of recommendation and level of evidence. Several questions addressed in this document either do not lend themselves to clinical trials or are rare disease entities, and in these instances recommendations are based on consensus expert opinion. Furthermore, specific recommendations, even when supported by substantial data, do not replace the need for clinical judgment and patient-specific decision-making. The recommendations were opened for public comment to Pediatric and Congenital Electrophysiology Society (PACES) members and underwent external review by the scientific and clinical document committee of the Heart Rhythm Society (HRS), the science advisory and coordinating committee of the American Heart Association (AHA), the American College of Cardiology (ACC), and the Association for European Paediatric and Congenital Cardiology (AEPC). The document received endorsement by all the collaborators and the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). This document is expected to provide support for clinicians and patients to allow for appropriate CIED use, appropriate CIED management, and appropriate CIED follow-up in pediatric patients. 相似文献
854.
Kutay İçöz Tayyibe Gerçek Ayşegül Murat Servet Özcan Ekrem Ünal 《Biotechnology progress》2019,35(1):e2737
One way to monitor minimal residual disease (MRD) is to screen cells for multiple surface markers using flow cytometry. In order to develop an alternative microfluidic based method, isolation of B type acute lymphoblastic cells using two types of antibodies should be investigated. The immunomagnetic beads coated with various antibodies are used to capture the B type acute lymphoblastic cells. Single beads, two types of beads and surface immobilized antibody were used to measure the capture efficiency. Both micro and nanosize immunomagnetic beads can be used to capture B type acute lymphoblastic cells with a minimum efficiency of 94% and maximum efficiency of 98%. Development of a microfluidic based biochip incorporating immunomagnetic beads and surface immobilized antibodies for monitoring MRD can be an alternative to current cost and time inefficient laboratory methods. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 35: e2737, 2019 相似文献